资讯

Novartis will acquire Regulus Therapeutics for up to $1.7B, boosting its kidney drug pipeline with lead candidate farabursen.
Novartis has agreed to acquire US-based Regulus Therapeutics and its oligonucleotide, farabursen, to bolster its renal ...
Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...
Woman baffled by painful periods had huge ovarian cyst filled with hair and teeth - Valentina Milanova was told she might ...
A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...
Despite the diagnosis, Valentina continued to grapple with cysts, severe pain, bloating, and heavy bleeding. Her personal ...